OA05707A - Nouvelles quinazolines, leurs procédés d'obtention et leur application à la thérapeutique - Google Patents

Nouvelles quinazolines, leurs procédés d'obtention et leur application à la thérapeutique

Info

Publication number
OA05707A
OA05707A OA56223A OA56223A OA05707A OA 05707 A OA05707 A OA 05707A OA 56223 A OA56223 A OA 56223A OA 56223 A OA56223 A OA 56223A OA 05707 A OA05707 A OA 05707A
Authority
OA
OAPI
Prior art keywords
therapy
application
production processes
quinazolines
new
Prior art date
Application number
OA56223A
Other languages
English (en)
Original Assignee
Science Union Et Cie Ste Franc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union Et Cie Ste Franc filed Critical Science Union Et Cie Ste Franc
Publication of OA05707A publication Critical patent/OA05707A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
OA56223A 1976-07-14 1977-07-12 Nouvelles quinazolines, leurs procédés d'obtention et leur application à la thérapeutique OA05707A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29317/76A GB1583753A (en) 1976-07-14 1976-07-14 Piperidine derivatives processes for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
OA05707A true OA05707A (fr) 1981-05-31

Family

ID=10289639

Family Applications (1)

Application Number Title Priority Date Filing Date
OA56223A OA05707A (fr) 1976-07-14 1977-07-12 Nouvelles quinazolines, leurs procédés d'obtention et leur application à la thérapeutique

Country Status (12)

Country Link
US (1) US4166117A (fr)
JP (1) JPS5334784A (fr)
BE (1) BE856784A (fr)
CA (1) CA1103671A (fr)
CH (1) CH625518A5 (fr)
DE (1) DE2731299A1 (fr)
ES (2) ES460699A1 (fr)
FR (1) FR2361385A1 (fr)
GB (1) GB1583753A (fr)
NL (1) NL7707785A (fr)
OA (1) OA05707A (fr)
SU (1) SU751324A3 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3066434D1 (en) * 1979-11-21 1984-03-08 Kyowa Hakko Kogyo Kk Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
US4344945A (en) * 1980-03-10 1982-08-17 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
PH23565A (en) * 1986-09-05 1989-08-25 Sumitomo Chemical Co Novel pyrimidinylpyrimidine derivatives and a plant disease protectant containing them as the active ingredient
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
EP0638567A4 (fr) * 1993-02-18 1995-05-10 Kyowa Hakko Kogyo Kk Inhibiteur de l'incorporation d'adenosine.
JP2959765B2 (ja) * 1997-12-12 1999-10-06 日本たばこ産業株式会社 ３−ピペリジル−４−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
US6258819B1 (en) * 1999-08-05 2001-07-10 Syntex (U.S.A.) Llc Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
US7521455B2 (en) * 2004-02-13 2009-04-21 Banyu Pharmaceutical Co. Ltd. Fused ring 4-oxopyrimidine derivative
AR065081A1 (es) * 2007-01-29 2009-05-13 Xenon Pharmaceuticals Inc Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica
US9040533B2 (en) 2012-12-27 2015-05-26 Purdue Pharma L.P. Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
CN108026095B (zh) 2015-09-23 2021-07-27 詹森药业有限公司 新化合物
HRP20220012T1 (hr) 2015-09-23 2022-04-01 Janssen Pharmaceutica Nv Bi-heteroaril supstituirani 1,4-benzodiazepini i njihova upotreba za liječenje raka

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2694711A (en) * 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
US3086910A (en) * 1960-03-09 1963-04-23 Wallace & Tiernan Inc Central nervous system depressants 3-(2'-pyridyl)-4-quinazolones
US3257397A (en) * 1963-07-26 1966-06-21 Rexall Drug Chemical Substituted 2, 3-dihydro-4(1h)-quinazolinones
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions

Also Published As

Publication number Publication date
CA1103671A (fr) 1981-06-23
FR2361385A1 (fr) 1978-03-10
CH625518A5 (fr) 1981-09-30
DE2731299A1 (de) 1978-01-19
FR2361385B1 (fr) 1983-10-07
JPS5334784A (en) 1978-03-31
NL7707785A (nl) 1978-01-17
US4166117A (en) 1979-08-28
ES460699A1 (es) 1978-12-01
ES472563A1 (es) 1979-10-16
GB1583753A (en) 1981-02-04
SU751324A3 (ru) 1980-07-23
BE856784A (fr) 1978-01-13

Similar Documents

Publication Publication Date Title
FR2338928A1 (fr) Nouvelles n-phenyl-n'-benzoylurees, leur procede de preparation et leur application comme insecticides
BE860774A (fr) "1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines trisubstituees, leur preparation et leurs applications therapeutiques
BE855669A (fr) Production de bioxyde d'uranium
BE888371Q (fr) Bracelet d'identite,
OA05707A (fr) Nouvelles quinazolines, leurs procédés d'obtention et leur application à la thérapeutique
FR2281408A1 (fr) Colorants disazoiques, leur procede d'obtention et leurs applications
BE851893A (fr) Nouvelles aryl-3 oxazolidinones-2, leur procede de preparation et leur application en therapeutique
BE880591A (fr) Nouvelles 1,4-dihydropyridines, leur preparation et leur application comme medicaments
BE846452A (fr) Nouvelles pyrimidones, leur procede de preparation et leur applicationtherapeutique
BE841537A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
FR2319343A1 (fr) Nouvelles guanidines, leur procede de preparation et leur application
TR20150A (tr) Tiyazoli'sinamik asit nitrilleri bunlarin imalati ve pestitler o'arak kullanilmalari
OA06060A (fr) Nouveaux thiopropionamides et leurs procédés d'obtention.
OA06139A (fr) Nouveaux thiobutyramides substitués et leurs procédés d'obtention.
IT1085360B (it) 1-azolil-4-idrossi-butan-derivati,processo per la loro produzione nonche' loro impiego come funghicidi e battericidi
BE845497A (fr) 3-phenylspiro-(isobenzofuranne-1,4'-pipieridine)-sulfenamides, leur procede de preparation et leurs applications
OA06415A (fr) Nouvelles trifluoroéthylamines substituées, leurs procédés d'obtention et leur emploi comme médicament.
FR2319341A1 (fr) Nouvelles guanidines ou thiourees, leur procede de preparation et leur application
BE841536A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
BE843231A (fr) Composition phosphorescente et son procede d'obtention
FR2353520A1 (fr) 1-aryloxy-2-hydroxy-3-aminopropanes, leur procede de preparation et leurs applications therapeutiques
BE876557A (fr) Nouvelles 1,2,4-triazolidin-3-ones ou -thiones et leurs methodes de preparation
OA08564A (fr) Nouveaux ortho-anisamides, leur procédé d'obtention et leurs applications thérapeutiques.
BE859213A (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
IT1081750B (it) 1-acilossi-1-fen il-2-azolil-etani,processi per la loro produzione nonche' loro impiego come funghicidi e namatocidi